Ramirez, Baby Girl .
HRN: 26-54-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/16/2025
01/23/2025
IV
25 Mg
Q24H
PCAP-C
Rejected
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines